FDA advisers vote against experimental ALS treatment pushed by patients
WASHINGTON — Federal health advisers voted overwhelmingly against an experimental treatment for Lou Gehrig’s disease at a Wednesday meeting prompted by years of patient efforts seeking access to the unproven …